Objectives:
To investigate the potential risk factors for endoscopic retrograde cholangiopancreatography (ERCP) complications and to identify whether the risk factors are different for pancreatitis and asymptomatic hyperamylasemia.
Methods:
Consecutive ERCP procedures were studied at 14 centers in China from May 2006 to April 2007. The complications after the patients' first-only procedures were evaluated. Multivariate analysis based on the first-only procedures was used to identify the risk factors.
Results:
A total of 3,178 procedures were performed on 2,691 patients. Overall, complications developed in 213 (7.92%) patients, pancreatitis in 116 (4.31%), and asymptomatic hyperamylasemia in 396 (14.72%). In the multivariate analysis, female gender (adjusted odds ratios (ORs): 1.52, 95% confidence interval (CI): 1.14-2.02, P=0.004), periampullary diverticulum (OR: 2.02, 95% CI: 1.49-2.73, P<0.001), cannulation time >10 min (OR: 1.51, 95% CI: 1.08-2.10, P=0.016), > or =1 pancreatic deep wire pass (OR: 1.80, 95% CI: 1.33-2.42, P<0.001), and needle-knife precut (OR: 2.70, 95% CI: 1.42-5.14, P=0.002) were risk factors for overall complications. Female gender (OR: 1.84, 95% CI: 1.25-2.70, P=0.002), age < or =60 year (OR: 1.59, 95% CI: 1.06-2.39, P=0.025), cannulation time>10 min (OR: 1.76, 95% CI: 1.13-2.74, P=0.012), > or =1 pancreatic deep wire pass (OR: 2.77, 95% CI: 1.79-4.30, P<0.001), and needle-knife precut (OR: 4.34, 95% CI: 1.92-9.79, P<0.001) were risk factors for pancreatitis. Cannulation time>10 min (OR: 1.96, 95% CI: 1.52-2.54, P<0.001), > or =1 pancreatic deep wire pass (OR: 2.24, 95% CI: 1.74-2.89, P<0.001), needle-knife precut (OR: 2.34, 95% CI: 1.32-4.14, P=0.004), and major papilla pancreatic sphincterotomy (OR: 1.71, 95% CI: 1.23-2.37, P=0.001) were risk factors for asymptomatic hyperamylasemia.
Conclusions:
Patient-related factors are as important as procedure-related factors in determining high-risk predictors for post-ERCP overall complications and pancreatitis. However, the risk factors for asymptomatic hyperamylasemia may be mostly procedure related.
Citing Articles
A new preprocedural predictive risk model for post-endoscopic retrograde cholangiopancreatography pancreatitis: The SuPER model.
Sugimoto M, Takagi T, Suzuki T, Shimizu H, Shibukawa G, Nakajima Y
Elife. 2025; 13.
PMID: 39819489
PMC: 11741517.
DOI: 10.7554/eLife.101604.
Hypothermia-associated acute pancreatitis: A multicenter prospective observational study.
Takahashi M, Takauji S, Hayakawa M
Acute Med Surg. 2025; 12(1):e70033.
PMID: 39776953
PMC: 11702497.
DOI: 10.1002/ams2.70033.
Prospective validation and revision of predictive models for post-ERCP pancreatitis: focus on procedure-related factors and a novel risk stratification approach.
Park C, Park S, Lee K, Park D, Cha H, Choi A
Surg Endosc. 2024; 39(2):1207-1216.
PMID: 39738907
DOI: 10.1007/s00464-024-11464-9.
Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Novel Mechanisms and Prevention by Drugs.
Akshintala V, Boparai I, Barakat M, Husain S
United European Gastroenterol J. 2024; 13(1):78-85.
PMID: 39711464
PMC: 11866316.
DOI: 10.1002/ueg2.12732.
Comprehensive audit of gastrointestinal endoscopy adverse events: Emphasizing quality indicators and economic impact with the AIG-AGREE modification.
Katrevula A, Singla N, Rughwani H, Jagtap N, Katukuri G, Godbole S
Endosc Int Open. 2024; 12(10):E1242-E1250.
PMID: 39474484
PMC: 11518629.
DOI: 10.1055/a-2435-5445.
Real-world evidence comparing early and late pancreatic stent placement to prevent post-ERCP pancreatitis.
Wang S, Bai B, Huang Q, Fang Y, Zhang C, Chen X
Endosc Int Open. 2024; 12(10):E1162-E1170.
PMID: 39411361
PMC: 11479794.
DOI: 10.1055/a-2409-1285.
Impact of difficult biliary cannulation on post-ERCP pancreatitis: secondary analysis of the stent versus indomethacin trial dataset.
Han S, Zhang J, Durkalski-Mauldin V, Foster L, Serrano J, Cote G
Gastrointest Endosc. 2024; 101(3):617-628.
PMID: 39389431
PMC: 11875935.
DOI: 10.1016/j.gie.2024.10.003.
Endoscopic assessment of minor papilla morphology: Predictors of successful cannulation and procedural pancreatitis risk in minor papilla endotherapy.
Kuraishi Y, Nakamura A, Kondo S, Yanagisawa T, Horiuchi I, Minamisawa M
J Hepatobiliary Pancreat Sci. 2024; 31(12):926-934.
PMID: 39252430
PMC: 11660995.
DOI: 10.1002/jhbp.12068.
The efficacy and safety of laparoscopic common bile duct exploration with primary duct closure for cholecystolithiasis combined with choledocholithiasis.
Teng D, Xu Y, Yang Q, Zhang W
Clin Case Rep. 2024; 12(9):e9414.
PMID: 39238506
PMC: 11375023.
DOI: 10.1002/ccr3.9414.
Precut Over a Pancreatic Duct Stent Versus Transpancreatic Precut Sphincterotomy for Difficult Biliary Cannulation in Endoscopic Retrograde Cholangiopancreatography: A Retrospective Cohort Study.
Qi Y, Li Q, Yao W, Wu Y, Li N
Dig Dis Sci. 2024; 69(10):3962-3969.
PMID: 39215869
PMC: 11489202.
DOI: 10.1007/s10620-024-08603-6.
Prediction for post-ERCP pancreatitis in non-elderly patients with common bile duct stones: a cross-sectional study at a major Chinese tertiary hospital (2015-2023).
Yan C, Zheng J, Tang H, Fang C, Zhu J, Feng H
BMC Med Inform Decis Mak. 2024; 24(1):143.
PMID: 38807169
PMC: 11134846.
DOI: 10.1186/s12911-024-02541-z.
Outcomes predictors in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stent: Systematic review and meta-analysis.
Fugazza A, Khalaf K, Spadaccini M, Facciorusso A, Colombo M, Andreozzi M
Endosc Int Open. 2024; 12(3):E456-E462.
PMID: 38550768
PMC: 10978093.
DOI: 10.1055/a-2271-2145.
Adverse Events in Endoscopic Retrograde Cholangiopancreticography for Choledocholithiasis: A Holistic Perspective.
Cankurtaran R, Ersoy O
Cureus. 2024; 16(2):e53375.
PMID: 38435169
PMC: 10908872.
DOI: 10.7759/cureus.53375.
Noninvasive rapid urinary trypsinogen-2 dipstick test for early exclusion of post-endoscopic retrograde cholangiopancreatography pancreatitis within hours after endoscopic retrograde cholangiopancreatography: Clinical diagnosis and considerations.
Hama K, Sofuni A, Nakatsubo R, Tsuchiya T, Tanaka R, Tonozuka R
DEN Open. 2024; 4(1):e336.
PMID: 38389803
PMC: 10881900.
DOI: 10.1002/deo2.336.
Risk factors for post‑retrograde cholangiopancreatography pancreatitis in patients with common bile duct stones: A meta‑analysis.
Zhou B, Zhao L, Xing X, Wang H, Kuwantai A, Chen K
Exp Ther Med. 2023; 27(1):32.
PMID: 38125338
PMC: 10731401.
DOI: 10.3892/etm.2023.12320.
Promising Outcomes of Modified ALPPS for Staged Hepatectomy in Cholangiocarcinoma.
Mehrabi A, Golriz M, Ramouz A, Khajeh E, Hammad A, Hackert T
Cancers (Basel). 2023; 15(23).
PMID: 38067316
PMC: 10705795.
DOI: 10.3390/cancers15235613.
ERCP in patients over 90 years old: Safety and efficacy comparison with a younger cohort.
Colmenero Gargari A, Melgar Somoza F, Vera J, Micames C
Endosc Int Open. 2023; 11(9):E893-E898.
PMID: 37810900
PMC: 10558256.
DOI: 10.1055/a-2153-7094.
Pharmacological and Endoscopic Interventions for Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Palomera-Tejeda E, Shah M, Attar B, Shah H, Sharma B, Oleas R
Gastroenterology Res. 2023; 16(3):149-156.
PMID: 37351082
PMC: 10284647.
DOI: 10.14740/gr1620.
Safety and feasibility of opening window fistulotomy as a new precutting technique for primary biliary access in endoscopic retrograde cholangiopancreatography.
Kuraishi Y, Hara K, Haba S, Kuwahara T, Okuno N, Yanaidani T
Clin Endosc. 2023; 56(4):490-498.
PMID: 37157966
PMC: 10393574.
DOI: 10.5946/ce.2022.130.
Efficacy and safety of endoscopic retrograde cholangiopancreatography in patients over 75 years of age.
Wang S, Lu Q, Zhou Y, Zhang H
J Minim Access Surg. 2023; 19(2):193-201.
PMID: 37056083
PMC: 10246631.
DOI: 10.4103/jmas.jmas_325_21.